Olga Vladimirovna Kostina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga Vladimirovna Kostina has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana Vladimirovna Zhilyaeva
Privolzhsky Research Medical University
6 shared publications - Elena Anatol'Evna Galova
Privolzhsky Research Medical University
5 shared publications - Galina Elevna Mazo
Department of Social neuropsychiatry V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology Saint-Petersburg Russia
5 shared publications - Anna Sergeevna Piatoikina
Clinical Psychiatric Hospital No 1 of Nizhny Novgorod
4 shared publications - Marina V. Presnyakova
Privolzhsky Research Medical University
4 shared publications - Artem Sergeevich Pushkin
Privolzhsky Research Medical University
3 shared publications
Latest Publications
- Open Access
- 25 September 2025
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 59 (3) , 60-70
Association of hematological coefficients with markers of inflammation and oxidative stress in schizophrenia: results of a pilot analysis
Relevance. To date, there is convincing evidence in favour of the immuno-inflammatory hypothesis of the etiopathogenesis of schizophrenia. As markers of immuno-inflammatory disorders in schizophrenia, a small number of studies have examined haematological indices (HI) and systemic inflammation coefficients (SIC): neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR) and platelet-lymphocyte ratio (PLR). Considering that HI may hypothetically reflect immuno-inflammatory processes in schizophrenia, it is relevant to assess their relationship with other known biochemical markers of inflammation and oxidative stress in this disease. The aim of this study was to evaluate the association of HI with biochemical markers of inflammation and oxidative stress in schizophrenia, as well as with the severity of clinical symptoms. Materials and methods: 50 patients with schizophrenia were examined: 42 women, 8 men, age 36 [7] years (median and interquartile range, hereafter Me [Q1; Q3]). Clinical assessment was performed using the Schizophrenia Positive and Negative Syndrome Scale and the Calgary Depression Scale for Schizophrenia. HI, homocysteine (Hc), tetrahydrobioterine (BH4), reduced glutathione (GSH), interleukin-6 (IL-6), C-reactive protein (CRP) and tumour necrosis factor-alpha (TNF-a) were studied. Results: Serum CRP levels were significantly correlated with leukocyte count, total monocyte, basophil and eosinophil counts, and granulocyte counts, but not with SIC (NLP, MLR and PLR). TNF-a has stronger direct correlations with a number of HI (granulocyte and erythrocyte counts, leukocyte counts at the level of trend towards significance) and coefficients (NLP, MLR at the level of trend). Conclusions: HI in the studied sample of patients with schizophrenia correlate with the data obtained by foreign authors, which indicates the prospect of studying this topic in the Russian population. Further evaluation of the relationship between HI (SIC) and serum TNF-a seems relevant. The study of associations of biochemical immuno-inflammatory markers with SIC further requires a thorough assessment of the stage of disease development, duration of its course, peculiarities of response to therapy.
- 25 September 2025
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 59 (3) , 60-70
Open AccessAssociation of hematological coefficients with markers of inflammation and oxidative stress in schizophrenia: results of a pilot analysis
Relevance. To date, there is convincing evidence in favour of the immuno-inflammatory hypothesis of the etiopathogenesis of schizophrenia. As markers of immuno-inflammatory disorders in schizophrenia, a small number of studies have examined haematological indices (HI) and systemic inflammation coefficients (SIC): neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR) and platelet-lymphocyte ratio (PLR). Considering that HI may hypothetically reflect immuno-inflammatory processes in schizophrenia, it is relevant to assess their relationship with other known biochemical markers of inflammation and oxidative stress in this disease. The aim of this study was to evaluate the association of HI with biochemical markers of inflammation and oxidative stress in schizophrenia, as well as with the severity of clinical symptoms. Materials and methods: 50 patients with schizophrenia were examined: 42 women, 8 men, age 36 [7] years (median and interquartile range, hereafter Me [Q1; Q3]). Clinical assessment was performed using the Schizophrenia Positive and Negative Syndrome Scale and the Calgary Depression Scale for Schizophrenia. HI, homocysteine (Hc), tetrahydrobioterine (BH4), reduced glutathione (GSH), interleukin-6 (IL-6), C-reactive protein (CRP) and tumour necrosis factor-alpha (TNF-a) were studied. Results: Serum CRP levels were significantly correlated with leukocyte count, total monocyte, basophil and eosinophil counts, and granulocyte counts, but not with SIC (NLP, MLR and PLR). TNF-a has stronger direct correlations with a number of HI (granulocyte and erythrocyte counts, leukocyte counts at the level of trend towards significance) and coefficients (NLP, MLR at the level of trend). Conclusions: HI in the studied sample of patients with schizophrenia correlate with the data obtained by foreign authors, which indicates the prospect of studying this topic in the Russian population. Further evaluation of the relationship between HI (SIC) and serum TNF-a seems relevant. The study of associations of biochemical immuno-inflammatory markers with SIC further requires a thorough assessment of the stage of disease development, duration of its course, peculiarities of response to therapy.
- 23 January 2025
- Published by Alfmed LLC in Medical alphabet
- No. 35,p. 73-78
Pathogenetic and prognostic aspects of copper and zinc deficiency in severely burned patients
Objective. To study the copper and zinc content in the severely burned patients’ blood serum and evaluate their capabilities as prognostic criteria for the burn disease outcome.Materials and methods. 37 patients with a burn area of 50,7±17,2 % of the body surface were examined, 7 of them died. The content of copper, zinc, albumin, globulins and prealbumin in blood serum was assessed within 14 days after receiving thermal injury.Results. A copper and zinc deficiency was found during the burn shock. In the future, the copper levels normalization and a tendency to the zinc concentration increase with normalization by 14 days after burn injury are noted. The micronutrient deficiency correlation with the albumin, prealbumin and globulins levels was found. The conjugacy between hypocyncemia and hypocupremia with the sepsis presence and the death probability was revealed. A decrease in zinc levels below 4,7 mmol/l leads to a 24-fold increase in the death chances and in copper content below 13 mmol/l – to a 10–fold increase in the chances. The sensitivity and specificity of the zinc concentration threshold value assessment was 71 % and 90 %, respectively, and the copper concentration was 80 % and 75 % respectively.Conclusion. During the burn shock hypocupremia and hypocyncemia are detected. Further normalization of the copper level and a tendency to zinc concentration normalization were revealed. Zinc and copper concentrations can serve as additional sepsis biomarkers. Threshold values of zinc and copper concentrations in blood serum have been determined which determine the fatal outcome risk of burn disease.
- 23 January 2025
- Published by Alfmed LLC in Medical alphabet
- No. 35,p. 73-78
Pathogenetic and prognostic aspects of copper and zinc deficiency in severely burned patients
Objective. To study the copper and zinc content in the severely burned patients’ blood serum and evaluate their capabilities as prognostic criteria for the burn disease outcome.Materials and methods. 37 patients with a burn area of 50,7±17,2 % of the body surface were examined, 7 of them died. The content of copper, zinc, albumin, globulins and prealbumin in blood serum was assessed within 14 days after receiving thermal injury.Results. A copper and zinc deficiency was found during the burn shock. In the future, the copper levels normalization and a tendency to the zinc concentration increase with normalization by 14 days after burn injury are noted. The micronutrient deficiency correlation with the albumin, prealbumin and globulins levels was found. The conjugacy between hypocyncemia and hypocupremia with the sepsis presence and the death probability was revealed. A decrease in zinc levels below 4,7 mmol/l leads to a 24-fold increase in the death chances and in copper content below 13 mmol/l – to a 10–fold increase in the chances. The sensitivity and specificity of the zinc concentration threshold value assessment was 71 % and 90 %, respectively, and the copper concentration was 80 % and 75 % respectively.Conclusion. During the burn shock hypocupremia and hypocyncemia are detected. Further normalization of the copper level and a tendency to zinc concentration normalization were revealed. Zinc and copper concentrations can serve as additional sepsis biomarkers. Threshold values of zinc and copper concentrations in blood serum have been determined which determine the fatal outcome risk of burn disease.
- 5 August 2023
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 73 (7-8) , 628-634
Gender-related Characteristics of Oxidative Stress Severity and Cognitive Impairment in Patients With Schizophrenia
The gender specificity of the clinical and psychopathological features of schizophrenia is an important factor in this disease. Gender features of neurocognitive deficit in schizophrenia and associated functional and structural disorders of the brain activity are of particular interest to researchers. There are several potential pathogenetic factors of this disease associated with gender, one of which is considered to be oxidative stress. Stress-induced cell death in the prefrontal and anterior frontal regions and reduced brain volume in these regions lead to cognitive and executive decline in patients with schizophrenia. Despite the great interest in the gender factor in schizophrenia pathogenesis, there are currently very few studies on gender differences in the severity of redox imbalance in patients with schizophrenia and their association with neurocognitive deficit. The aim of the study was to reveal the gender specificity of oxidative stress severity in patients with schizophrenia and assess its association with the severity of neurocognitive deficit. The study included 125 patients with schizophrenia and 75 sex- and age-matched healthy volunteers. Sociodemographic and clinical data were studied. Cognitive functions were evaluated using BACS. Blood samples were taken for biochemical studies of the levels of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) in erythrocyte hemolysate, malonic dialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazones (ADNPH), ketone-2,4-dinitrophenylhydrazones (KDNPH) in plasma. Levels of oxidative stress markers were assessed by spectrophotometric method. In a sample of patients with schizophrenia, a statistically significantly higher activity of CAT was revealed among women compared to men (T=2.25; p=0.025), however, it was lower than in healthy volunteers. But, at the same time, a higher concentration of protein peroxidation products was found in the peripheral blood of women than in men (ADNPH MCO: T=2.52; p=0.013; KDNPH MCO: Z=-2.26; p=0.017). In the group of healthy volunteers, in contrast to patients with schizophrenia, gender differences in markers of oxidative stress were not found. In women with schizophrenia, single correlations were found between the level of the lipid peroxidation product MDA and the test scores for verbal memory (R=-0.36; p=0.006) and working memory (R=-0.36; p=0.006), antioxidant enzyme activity SOD and motor skills (R=-0.26; p=0.047). In men, on the contrary, multiple correlations of both antioxidants and, mainly, products of lipid and protein peroxidation with cognitive functions assessed using BACS were found. Despite the fact that oxidative stress is more pronounced in women than in men with schizophrenia, associations of redox imbalance with neurocognitive deficit in women is much less pronounced than in men.
- 5 August 2023
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 73 (7-8) , 628-634
Gender-related Characteristics of Oxidative Stress Severity and Cognitive Impairment in Patients With Schizophrenia
The gender specificity of the clinical and psychopathological features of schizophrenia is an important factor in this disease. Gender features of neurocognitive deficit in schizophrenia and associated functional and structural disorders of the brain activity are of particular interest to researchers. There are several potential pathogenetic factors of this disease associated with gender, one of which is considered to be oxidative stress. Stress-induced cell death in the prefrontal and anterior frontal regions and reduced brain volume in these regions lead to cognitive and executive decline in patients with schizophrenia. Despite the great interest in the gender factor in schizophrenia pathogenesis, there are currently very few studies on gender differences in the severity of redox imbalance in patients with schizophrenia and their association with neurocognitive deficit. The aim of the study was to reveal the gender specificity of oxidative stress severity in patients with schizophrenia and assess its association with the severity of neurocognitive deficit. The study included 125 patients with schizophrenia and 75 sex- and age-matched healthy volunteers. Sociodemographic and clinical data were studied. Cognitive functions were evaluated using BACS. Blood samples were taken for biochemical studies of the levels of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) in erythrocyte hemolysate, malonic dialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazones (ADNPH), ketone-2,4-dinitrophenylhydrazones (KDNPH) in plasma. Levels of oxidative stress markers were assessed by spectrophotometric method. In a sample of patients with schizophrenia, a statistically significantly higher activity of CAT was revealed among women compared to men (T=2.25; p=0.025), however, it was lower than in healthy volunteers. But, at the same time, a higher concentration of protein peroxidation products was found in the peripheral blood of women than in men (ADNPH MCO: T=2.52; p=0.013; KDNPH MCO: Z=-2.26; p=0.017). In the group of healthy volunteers, in contrast to patients with schizophrenia, gender differences in markers of oxidative stress were not found. In women with schizophrenia, single correlations were found between the level of the lipid peroxidation product MDA and the test scores for verbal memory (R=-0.36; p=0.006) and working memory (R=-0.36; p=0.006), antioxidant enzyme activity SOD and motor skills (R=-0.26; p=0.047). In men, on the contrary, multiple correlations of both antioxidants and, mainly, products of lipid and protein peroxidation with cognitive functions assessed using BACS were found. Despite the fact that oxidative stress is more pronounced in women than in men with schizophrenia, associations of redox imbalance with neurocognitive deficit in women is much less pronounced than in men.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 6
Fatty acid-binding protein as a marker of intestinal damage and potential predictor of mortality in acute period of burn disease
Objective. To study intestinal fatty acid-binding protein (I-FABP) changes in acute period of burn disease and evaluate the capabilities of this biomarker for prediction of mortality. Material and methods. There were 38 patients with burns of 50.7±17.2% of body surface; 7 patients died. Blood sampling was carried out in 1, 2, 3, 6±2, 9±2 and 11±2 days after injury. We analyzed I-FABP concentration, free radical processes according to biochemiluminescence analysis, lipid peroxidation and activity of catalase and superoxide dismutase. Results. I-FABP was increased throughout the study. There was a correlation between I-FABP level and pro-/antioxidant imbalance. Deceased patients had 4—37 times higher concentration of I-FABP compared to survivors. The maximum values were recorded in patients with early sepsis and fatal outcome. Logistic regression revealed a relationship between mortality and high I-FABP level. I-FABP >143.6 pg/ml had good specificity (71.4%), sensitivity (81.5%) and diagnostic efficacy (79%) regarding the risk of mortality. ROC analysis demonstrated acceptable informative value of I-FABP (AUC 0.783±0.137). Conclusion. Acute period of burn disease is accompanied by increased serum I-FABP. Enterocyte membrane damage is associated with imbalance between pro- and antioxidants. Increased I-FABP correlated with sepsis. I-FABP >143.6 pg/ml in severely burned patients has significant prognostic value for mortality.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 6
Fatty acid-binding protein as a marker of intestinal damage and potential predictor of mortality in acute period of burn disease
Objective. To study intestinal fatty acid-binding protein (I-FABP) changes in acute period of burn disease and evaluate the capabilities of this biomarker for prediction of mortality. Material and methods. There were 38 patients with burns of 50.7±17.2% of body surface; 7 patients died. Blood sampling was carried out in 1, 2, 3, 6±2, 9±2 and 11±2 days after injury. We analyzed I-FABP concentration, free radical processes according to biochemiluminescence analysis, lipid peroxidation and activity of catalase and superoxide dismutase. Results. I-FABP was increased throughout the study. There was a correlation between I-FABP level and pro-/antioxidant imbalance. Deceased patients had 4—37 times higher concentration of I-FABP compared to survivors. The maximum values were recorded in patients with early sepsis and fatal outcome. Logistic regression revealed a relationship between mortality and high I-FABP level. I-FABP >143.6 pg/ml had good specificity (71.4%), sensitivity (81.5%) and diagnostic efficacy (79%) regarding the risk of mortality. ROC analysis demonstrated acceptable informative value of I-FABP (AUC 0.783±0.137). Conclusion. Acute period of burn disease is accompanied by increased serum I-FABP. Enterocyte membrane damage is associated with imbalance between pro- and antioxidants. Increased I-FABP correlated with sepsis. I-FABP >143.6 pg/ml in severely burned patients has significant prognostic value for mortality.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
The effect of perioperative specialized enteral nutrition on postoperative period after redo surgeries in patients with periprosthetic hip joint infection
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить изменение концентрации транстиретина при ревизионных операциях у больных с перипротезной инфекцией тазобедренного сустава на фоне применения периоперационного энтерального питания. МАТЕРИАЛ И МЕТОДЫ В открытое проспективное рандомизированное простое слепое исследование включены 11 женщин и 20 мужчин (всего 31 пациент). Исследование проводили в двух группах больных. Больным выполняли оперативные вмешательства ревизионного протезирования тазобедренного сустава по поводу перипротезной инфекции. Пациентам 1-й группы (n=19) проводили комбинированную спинально-эпидуральную анестезию, дополнительное питание не назначали. Пациентам 2-й группы (n=12) обезболивание выполняли по той же методике, но за 3 дня до оперативного вмешательства назначали 500 мл/сут дополнительного энтерального питания на 10 сут. У пациентов обеих групп оценивали концентрацию транстиретина за 3 дня до операции и далее утром 1-х, 3-х, 5-х и 7-х суток. Для статистической обработки полученных данных применяли пакет программ SPSS Statistics. С целью проверки характера распределения вариационных рядов использовали критерий Колмогорова—Смирнова. Поскольку распределение в обеих выборках было нормальным, группы сравнивали с помощью t-критерия Стьюдента. РЕЗУЛЬТАТЫ Концентрация транстиретина была выше у пациентов группы с энтеральным питанием в 1-е сутки (p=0,003), на 3-и сутки (p=0,003), на 5-е сутки (p=0,024) и на 7-е сутки (p=0,033). Самые низкие значения данного показателя у пациентов обеих групп наблюдали на 3-и сутки после операции. ЗАКЛЮЧЕНИЕ Применение периоперационного энтерального питания у больных, оперированных по поводу хронической перипротезной инфекции тазобедренного сустава, сопровождается более высокой концентрацией транстиретина в послеоперационном периоде.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
The effect of perioperative specialized enteral nutrition on postoperative period after redo surgeries in patients with periprosthetic hip joint infection
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить изменение концентрации транстиретина при ревизионных операциях у больных с перипротезной инфекцией тазобедренного сустава на фоне применения периоперационного энтерального питания. МАТЕРИАЛ И МЕТОДЫ В открытое проспективное рандомизированное простое слепое исследование включены 11 женщин и 20 мужчин (всего 31 пациент). Исследование проводили в двух группах больных. Больным выполняли оперативные вмешательства ревизионного протезирования тазобедренного сустава по поводу перипротезной инфекции. Пациентам 1-й группы (n=19) проводили комбинированную спинально-эпидуральную анестезию, дополнительное питание не назначали. Пациентам 2-й группы (n=12) обезболивание выполняли по той же методике, но за 3 дня до оперативного вмешательства назначали 500 мл/сут дополнительного энтерального питания на 10 сут. У пациентов обеих групп оценивали концентрацию транстиретина за 3 дня до операции и далее утром 1-х, 3-х, 5-х и 7-х суток. Для статистической обработки полученных данных применяли пакет программ SPSS Statistics. С целью проверки характера распределения вариационных рядов использовали критерий Колмогорова—Смирнова. Поскольку распределение в обеих выборках было нормальным, группы сравнивали с помощью t-критерия Стьюдента. РЕЗУЛЬТАТЫ Концентрация транстиретина была выше у пациентов группы с энтеральным питанием в 1-е сутки (p=0,003), на 3-и сутки (p=0,003), на 5-е сутки (p=0,024) и на 7-е сутки (p=0,033). Самые низкие значения данного показателя у пациентов обеих групп наблюдали на 3-и сутки после операции. ЗАКЛЮЧЕНИЕ Применение периоперационного энтерального питания у больных, оперированных по поводу хронической перипротезной инфекции тазобедренного сустава, сопровождается более высокой концентрацией транстиретина в послеоперационном периоде.
- Open Access
- 1 January 2023
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 67 (6) , 330-333
RELATIONSHIP OF ZINC LEVEL WITH PATHOGENETICALLY SIGNIFICANT HOMEOSTASIS DISORDERS IN SEVERELY BURNED PATIENTS
The aim of the study was to assess the zinc content and identify the relationship between the concentration of this element and changes in the biochemical status of patients and markers of inflammation during burn shock. We examined 23 patients aged 45.3±16.1 years with burns of I-II-III degree, area of 31-80%. The serum concentrations of zinc, albumin, interleukin-6, C-reactive protein (CRP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined. The majority of patients (21/23) had severe hypocincemia, correlated with burn area (r=-0.53; p=0.008). A decrease in zinc levels during burn shock was associated with the development of hypoalbuminemia (r=0.52, p=0.01). The association of deviations in ALT and AST activity with changes in zinc concentration was revealed (-0.59<γ<-0.61, 0.008<p<0.009), which may indicate the role of hepatic dysfunction in the development of hypocinkemia. The development of a systemic inflammatory response was revealed. The correlation analysis revealed an association between the zinc and interleukin-6 levels (r=-0.63, p=0.03), as well as zinc and CRP (r=-0.41, p=0.04). From the first days after the injury, zinc deficiency is observed in severely burned patients, which is affected by an inflammatory reaction and hypoalbuminemia. Due to the fact that zinc is one of the key factors in maintaining homeostasis in the body, it is necessary to further study the molecular mechanisms of regulating the level of this trace element in burned patients and to develop ways to correct hypocinkemia that contribute to the effective treatment of burn disease.
- 1 January 2023
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 67 (6) , 330-333
Open AccessRELATIONSHIP OF ZINC LEVEL WITH PATHOGENETICALLY SIGNIFICANT HOMEOSTASIS DISORDERS IN SEVERELY BURNED PATIENTS
The aim of the study was to assess the zinc content and identify the relationship between the concentration of this element and changes in the biochemical status of patients and markers of inflammation during burn shock. We examined 23 patients aged 45.3±16.1 years with burns of I-II-III degree, area of 31-80%. The serum concentrations of zinc, albumin, interleukin-6, C-reactive protein (CRP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined. The majority of patients (21/23) had severe hypocincemia, correlated with burn area (r=-0.53; p=0.008). A decrease in zinc levels during burn shock was associated with the development of hypoalbuminemia (r=0.52, p=0.01). The association of deviations in ALT and AST activity with changes in zinc concentration was revealed (-0.59<γ<-0.61, 0.008<p<0.009), which may indicate the role of hepatic dysfunction in the development of hypocinkemia. The development of a systemic inflammatory response was revealed. The correlation analysis revealed an association between the zinc and interleukin-6 levels (r=-0.63, p=0.03), as well as zinc and CRP (r=-0.41, p=0.04). From the first days after the injury, zinc deficiency is observed in severely burned patients, which is affected by an inflammatory reaction and hypoalbuminemia. Due to the fact that zinc is one of the key factors in maintaining homeostasis in the body, it is necessary to further study the molecular mechanisms of regulating the level of this trace element in burned patients and to develop ways to correct hypocinkemia that contribute to the effective treatment of burn disease.
- Open Access
- 17 December 2022
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 56 (4) , 52-62
Biochemical disturbances in schizophrenia — a «window of opportunity»
Introduction: Currently, there is a large amount of data that inflammatory and oxidative stress biomarkers, pterin metabolism disturbances and other biochemical abnormalities are more often present in schizophrenia compared to general population. They may also play the role of etiopathogenetic factors in schizophrenia mechanisms. At the same time, there are no studies with an assessment of a wide range of correctable biochemical abnormalities in one sample of patients. Moreover, screening algorithms for the detection and personalized correction of controlled biomarkers have not been introduced into clinical practice yet. The aim of this work was to evaluate the prevalence of significant etiopathogenetic biochemical disturbances in patients with schizophrenia in order to justify the need for biochemical screening and correction of the corresponding abnormalities. Materials and methods: in the blood serum of 125 patients with schizophrenia and 95 healthy volunteers the levels of folate and cobalamin (B12) (chemiluminescent immunoassay on microparticles), homocysteine (HC, enzymatic analysis), tetrahydrobiopterin (BH4, competitive enzyme immunoassay, ELISA), reduced glutathione (GSH, spectrophotometry with Ellman’s reagent), interleukin-6 (IL-6, ELISA based on a three-stage «sandwich version») and C-reactive protein (CRP, immunoturbodimetric method) were evaluated. Results: In patients with schizophrenia the level of all studied serum biochemical markers, except for B12, was significantly different compared to healthy volunteers. The deviations levels of the studied parameters from the reference values in patients were statistically significantly higher in the markers of pterin metabolism (VH4: p = 0.0000; folates: p = 0.0000; HC: p = 0.0094). 29.6 % of patients were carriers of 4 or more studied biochemical abnormalities, while among healthy volunteers this occured in 5.3 % of cases (Xi2 = 19.2; p < 0.001). Conclusion: The results obtained raise the question for the need of monitoring principles for a number of biochemical markers in schizophrenia and their implementation in clinical practice.
- 17 December 2022
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 56 (4) , 52-62
Open AccessBiochemical disturbances in schizophrenia — a «window of opportunity»
Introduction: Currently, there is a large amount of data that inflammatory and oxidative stress biomarkers, pterin metabolism disturbances and other biochemical abnormalities are more often present in schizophrenia compared to general population. They may also play the role of etiopathogenetic factors in schizophrenia mechanisms. At the same time, there are no studies with an assessment of a wide range of correctable biochemical abnormalities in one sample of patients. Moreover, screening algorithms for the detection and personalized correction of controlled biomarkers have not been introduced into clinical practice yet. The aim of this work was to evaluate the prevalence of significant etiopathogenetic biochemical disturbances in patients with schizophrenia in order to justify the need for biochemical screening and correction of the corresponding abnormalities. Materials and methods: in the blood serum of 125 patients with schizophrenia and 95 healthy volunteers the levels of folate and cobalamin (B12) (chemiluminescent immunoassay on microparticles), homocysteine (HC, enzymatic analysis), tetrahydrobiopterin (BH4, competitive enzyme immunoassay, ELISA), reduced glutathione (GSH, spectrophotometry with Ellman’s reagent), interleukin-6 (IL-6, ELISA based on a three-stage «sandwich version») and C-reactive protein (CRP, immunoturbodimetric method) were evaluated. Results: In patients with schizophrenia the level of all studied serum biochemical markers, except for B12, was significantly different compared to healthy volunteers. The deviations levels of the studied parameters from the reference values in patients were statistically significantly higher in the markers of pterin metabolism (VH4: p = 0.0000; folates: p = 0.0000; HC: p = 0.0094). 29.6 % of patients were carriers of 4 or more studied biochemical abnormalities, while among healthy volunteers this occured in 5.3 % of cases (Xi2 = 19.2; p < 0.001). Conclusion: The results obtained raise the question for the need of monitoring principles for a number of biochemical markers in schizophrenia and their implementation in clinical practice.
- 6 July 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 153, 141-148
Tetrahydrobiopterin deficiency in schizophrenia: Biochemical and clinical aspects
- 6 July 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 153, 141-148
Tetrahydrobiopterin deficiency in schizophrenia: Biochemical and clinical aspects
- Open Access
- 17 April 2022
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 14 (2) , 18-25
Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study
Antipsychotics (AP) administration in schizophrenia patients is associated with several side effects (SE), in particular, with extrapyramidal (EP). Data suggests that oxidative damage to dopaminergic neurons in the EP system may be related to tardive dyskinesia and Parkinson's disease (PD) development, although data on the role of oxidative stress in the development of early EPSE of AP is lacking. Another poorly studied hypothesis of the EP-symptoms pathogenesis considers disorders of folate (pterin) metabolism.Objective: to evaluate the relationship between redox imbalance and pterin metabolism with the severity of early EPSE caused by AP used in the schizophrenia treatment.Patients and methods. The study included 50 patients with the first episode of schizophrenia. EP symptoms were evaluated using the UKU Side-Effect Rating Scale (“UKU-SERS-Clin” version). The levels of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazone, ketone-2,4-dinitrophenylhydrazone were assessed in blood plasma; levels of BH4, folate, cobalamin (vitamin B12), and homocysteine – in blood serum; superoxide dismutase (SOD) and catalase activity – in erythrocytes.Results and discussion. EPSE severity was inversely proportional inversely proportional to the GSH level and directly proportional to the SOD activity. EPSE severity was also associated with AP selectivity, but not with their dosages. However, AP selectivity was not associated with studied biochemical parameters. MDA level in patients prescribed with amantadine was lower than in other participants.Conclusion. Early AP-induced EPSE were associated with redox imbalance, which indicates the necessity for further research aiming at prevention of secondary neurodegenerative diseases in patients with schizophrenia receiving AP.
- 17 April 2022
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 14 (2) , 18-25
Open AccessAssociation between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study
Antipsychotics (AP) administration in schizophrenia patients is associated with several side effects (SE), in particular, with extrapyramidal (EP). Data suggests that oxidative damage to dopaminergic neurons in the EP system may be related to tardive dyskinesia and Parkinson's disease (PD) development, although data on the role of oxidative stress in the development of early EPSE of AP is lacking. Another poorly studied hypothesis of the EP-symptoms pathogenesis considers disorders of folate (pterin) metabolism.Objective: to evaluate the relationship between redox imbalance and pterin metabolism with the severity of early EPSE caused by AP used in the schizophrenia treatment.Patients and methods. The study included 50 patients with the first episode of schizophrenia. EP symptoms were evaluated using the UKU Side-Effect Rating Scale (“UKU-SERS-Clin” version). The levels of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), aldehyde-2,4-dinitrophenylhydrazone, ketone-2,4-dinitrophenylhydrazone were assessed in blood plasma; levels of BH4, folate, cobalamin (vitamin B12), and homocysteine – in blood serum; superoxide dismutase (SOD) and catalase activity – in erythrocytes.Results and discussion. EPSE severity was inversely proportional inversely proportional to the GSH level and directly proportional to the SOD activity. EPSE severity was also associated with AP selectivity, but not with their dosages. However, AP selectivity was not associated with studied biochemical parameters. MDA level in patients prescribed with amantadine was lower than in other participants.Conclusion. Early AP-induced EPSE were associated with redox imbalance, which indicates the necessity for further research aiming at prevention of secondary neurodegenerative diseases in patients with schizophrenia receiving AP.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (5)
Characteristics of changes in blood biochemical parameters during dynamic observation in patients with COVID-19 and in the post-COVID period
ЦЕЛЬ ИССЛЕДОВАНИЯ Провести анализ изменений биохимических показателей крови в остром периоде COVID-19, в периоде ранней и поздней реконвалесценции при динамическом наблюдении пациентов. МАТЕРИАЛ И МЕТОДЫ У 50 пациентов в остром периоде COVID-19 и в постковидном периоде исследовано содержание в сыворотке крови глюкозы, креатинина, мочевины, общего белка, альбумина, общего билирубина, трансаминаз, С-реактивного белка. РЕЗУЛЬТАТЫ В остром периоде COVID-19 и в постковидном периоде зафиксированы случаи гипергликемии (n=7 и n=6 соответственно), не связанные с наличием сахарного диабета в анамнезе. В течение COVID-19 уровень креатинина возрастал практически у каждого четвертого больного и нормализовался у большинства пациентов в периоде реконвалесценции. Повышенная активность трансаминаз за время болезни зафиксирована у 64% больных, у большинства пациентов в постковидном периоде показатели нормализовались. При госпитализации повышенное содержание общего билирубина определено у 1 пациента, через 10—14 дней — у 14% больных, в периоде реконвалесценции — у 6%. Течение болезни характеризовалось гипоальбуминемией и снижением концентрации общего белка на 19%. В периоде реконвалесценции регистрировали возрастание концентрации общего белка на 10%, через год после перенесенной инфекции отмечена нормализация уровня альбумина. Течение COVID-19 сопровождалось значительным увеличением уровня С-реактивного белка, снижавшемся в динамике наблюдений, через 2—3 мес повышение уровня сохранялось у 12%, через год — у 16% пациентов. ЗАКЛЮЧЕНИЕ Острый период COVID-19 характеризовался выраженными изменениями биохимических параметров крови. В постковидном периоде отклонения от нормы тех или иных показателей отмечены более чем у 30% пациентов. Это свидетельствует о необходимости динамического мониторинга лабораторных показателей, который может помочь предотвратить развитие сопутствующей патологии после перенесенного COVID-19.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (5)
Characteristics of changes in blood biochemical parameters during dynamic observation in patients with COVID-19 and in the post-COVID period
ЦЕЛЬ ИССЛЕДОВАНИЯ Провести анализ изменений биохимических показателей крови в остром периоде COVID-19, в периоде ранней и поздней реконвалесценции при динамическом наблюдении пациентов. МАТЕРИАЛ И МЕТОДЫ У 50 пациентов в остром периоде COVID-19 и в постковидном периоде исследовано содержание в сыворотке крови глюкозы, креатинина, мочевины, общего белка, альбумина, общего билирубина, трансаминаз, С-реактивного белка. РЕЗУЛЬТАТЫ В остром периоде COVID-19 и в постковидном периоде зафиксированы случаи гипергликемии (n=7 и n=6 соответственно), не связанные с наличием сахарного диабета в анамнезе. В течение COVID-19 уровень креатинина возрастал практически у каждого четвертого больного и нормализовался у большинства пациентов в периоде реконвалесценции. Повышенная активность трансаминаз за время болезни зафиксирована у 64% больных, у большинства пациентов в постковидном периоде показатели нормализовались. При госпитализации повышенное содержание общего билирубина определено у 1 пациента, через 10—14 дней — у 14% больных, в периоде реконвалесценции — у 6%. Течение болезни характеризовалось гипоальбуминемией и снижением концентрации общего белка на 19%. В периоде реконвалесценции регистрировали возрастание концентрации общего белка на 10%, через год после перенесенной инфекции отмечена нормализация уровня альбумина. Течение COVID-19 сопровождалось значительным увеличением уровня С-реактивного белка, снижавшемся в динамике наблюдений, через 2—3 мес повышение уровня сохранялось у 12%, через год — у 16% пациентов. ЗАКЛЮЧЕНИЕ Острый период COVID-19 характеризовался выраженными изменениями биохимических параметров крови. В постковидном периоде отклонения от нормы тех или иных показателей отмечены более чем у 30% пациентов. Это свидетельствует о необходимости динамического мониторинга лабораторных показателей, который может помочь предотвратить развитие сопутствующей патологии после перенесенного COVID-19.